QTMeds

Drug Database Monograph

HEMLIBRA 150 mg/mL

PENDING REVIEW

Active Ingredient: EMICIZUMAB

QTc Interval Status:

neutral

Clinical Description (Database Summary)

Scientific Sources / References

Analyse RCP (Automatique), id : 61529993

← Back to Prescription Analyzer